Literature DB >> 17378584

A single residue in leucyl-tRNA synthetase affecting amino acid specificity and tRNA aminoacylation.

Stanley W Lue1, Shana O Kelley.   

Abstract

Human mitochondrial leucyl-tRNA synthetase (hs mt LeuRS) achieves high aminoacylation fidelity without a functional editing active site, representing a rare example of a class I aminoacyl-tRNA synthetase (aaRS) that does not proofread its products. Previous studies demonstrated that the enzyme achieves high selectivity by using a more specific synthetic active site that is not prone to errors under physiological conditions. Interestingly, the synthetic active site of hs mt LeuRS displays a high degree of homology with prokaryotic, lower eukaryotic, and other mitochondrial LeuRSs that are less specific. However, there is one residue that differs between hs mt and Escherichia coli LeuRSs located on a flexible closing loop near the signature KMSKS motif. Here we describe studies indicating that this particular residue (K600 in hs mt LeuRS and L570 in E. coli LeuRS) strongly impacts aminoacylation in two ways: it affects both amino acid discrimination and transfer RNA (tRNA) binding. While this residue may not be in direct contact with the amino acid or tRNA substrate, substitutions of this position in both enzymes lead to altered catalytic efficiency and perturbations to the discrimination of leucine and isoleucine. In addition, tRNA recognition and aminoacylation is affected. These findings indicate that the conformation of the synthetic active site, modulated by this residue, may be coupled to specificity and provide new insights into the origins of selectivity without editing.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17378584      PMCID: PMC2518062          DOI: 10.1021/bi0618215

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  48 in total

1.  Errors from selective disruption of the editing center in a tRNA synthetase.

Authors:  T L Hendrickson; T K Nomanbhoy; P Schimmel
Journal:  Biochemistry       Date:  2000-07-18       Impact factor: 3.162

2.  A conserved threonine within Escherichia coli leucyl-tRNA synthetase prevents hydrolytic editing of leucyl-tRNALeu.

Authors:  R S Mursinna; T L Lincecum; S A Martinis
Journal:  Biochemistry       Date:  2001-05-08       Impact factor: 3.162

3.  Enlarging the amino acid set of Escherichia coli by infiltration of the valine coding pathway.

Authors:  V Döring; H D Mootz; L A Nangle; T L Hendrickson; V de Crécy-Lagard; P Schimmel; P Marlière
Journal:  Science       Date:  2001-04-20       Impact factor: 47.728

4.  Active-site assembly in glutaminyl-tRNA synthetase by tRNA-mediated induced fit.

Authors:  Nathan T Uter; John J Perona
Journal:  Biochemistry       Date:  2006-06-06       Impact factor: 3.162

5.  How methionyl-tRNA synthetase creates its amino acid recognition pocket upon L-methionine binding.

Authors:  L Serre; G Verdon; T Choinowski; N Hervouet; J L Risler; C Zelwer
Journal:  J Mol Biol       Date:  2001-03-02       Impact factor: 5.469

6.  Structural origins of amino acid selection without editing by cysteinyl-tRNA synthetase.

Authors:  Kate J Newberry; Ya-Ming Hou; John J Perona
Journal:  EMBO J       Date:  2002-06-03       Impact factor: 11.598

7.  Structural basis for anticodon recognition by discriminating glutamyl-tRNA synthetase.

Authors:  S Sekine ; O Nureki; A Shimada; D G Vassylyev; S Yokoyama
Journal:  Nat Struct Biol       Date:  2001-03

8.  Dual mode recognition of two isoacceptor tRNAs by mammalian mitochondrial seryl-tRNA synthetase.

Authors:  N Shimada; T Suzuki; K Watanabe
Journal:  J Biol Chem       Date:  2001-09-27       Impact factor: 5.157

9.  Mutational separation of two pathways for editing by a class I tRNA synthetase.

Authors:  Tamara L Hendrickson; Tyzoon K Nomanbhoy; Valérie de Crécy-Lagard; Shuya Fukai; Osamu Nureki; Shigeyuki Yokoyama; Paul Schimmel
Journal:  Mol Cell       Date:  2002-02       Impact factor: 17.970

10.  tRNA aminoacylation by arginyl-tRNA synthetase: induced conformations during substrates binding.

Authors:  B Delagoutte; D Moras; J Cavarelli
Journal:  EMBO J       Date:  2000-11-01       Impact factor: 11.598

View more
  5 in total

1.  Kinetic partitioning between synthetic and editing pathways in class I aminoacyl-tRNA synthetases occurs at both pre-transfer and post-transfer hydrolytic steps.

Authors:  Nevena Cvetesic; John J Perona; Ita Gruic-Sovulj
Journal:  J Biol Chem       Date:  2012-05-30       Impact factor: 5.157

2.  Degenerate connective polypeptide 1 (CP1) domain from human mitochondrial leucyl-tRNA synthetase.

Authors:  Qing Ye; Meng Wang; Zhi-Peng Fang; Zhi-Rong Ruan; Quan-Quan Ji; Xiao-Long Zhou; En-Duo Wang
Journal:  J Biol Chem       Date:  2015-08-13       Impact factor: 5.157

3.  Discovery of a novel class of boron-based antibacterials with activity against gram-negative bacteria.

Authors:  Vincent Hernandez; Thibaut Crépin; Andrés Palencia; Stephen Cusack; Tsutomu Akama; Stephen J Baker; Wei Bu; Lisa Feng; Yvonne R Freund; Liang Liu; Maliwan Meewan; Manisha Mohan; Weimin Mao; Fernando L Rock; Holly Sexton; Anita Sheoran; Yanchen Zhang; Yong-Kang Zhang; Yasheen Zhou; James A Nieman; Mahipal Reddy Anugula; El Mehdi Keramane; Kingsley Savariraj; D Shekhar Reddy; Rashmi Sharma; Rajendra Subedi; Rajeshwar Singh; Ann O'Leary; Nerissa L Simon; Peter L De Marsh; Shazad Mushtaq; Marina Warner; David M Livermore; M R K Alley; Jacob J Plattner
Journal:  Antimicrob Agents Chemother       Date:  2013-01-07       Impact factor: 5.191

4.  Evolutionary basis for the coupled-domain motions in Thermus thermophilus leucyl-tRNA synthetase.

Authors:  Kristina Mary Ellen Weimer; Brianne Leigh Shane; Michael Brunetto; Sudeep Bhattacharyya; Sanchita Hati
Journal:  J Biol Chem       Date:  2009-02-02       Impact factor: 5.157

5.  Resequencing DCDC5 in the Flanking Region of an LD-SNP Derived from a Kidney-Yang Deficiency Syndrome Family.

Authors:  Li Ping Zhou; Wei Wei Liu; Tian E Zhang; Wei Hong Li; Ling Ling Tan; Wan Zhen Li; Yu Hua Qin; Hong Ya Yang; Azure Duan; Mi Qu Wang; Wei Jun Ding
Journal:  Evid Based Complement Alternat Med       Date:  2011-05-05       Impact factor: 2.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.